SNAP-8 is strictly for laboratory research and is commonly employed in the following investigational areas:

SNARE Complex Modulation

SNAP-8 is utilized as a chemical probe to study the biophysics of SNARE complex assembly. Researchers use this peptide to map the binding kinetics of synaptobrevin, syntaxin, and SNAP-25, and to quantify how structural analogues can destabilize this fusion machinery in isolated synaptic models.

Neurotransmitter Release Dynamics

In vitro neurobiological studies employ SNAP-8 to observe its inhibitory impact on vesicular exocytosis. Investigations focus on quantifying the reduction of acetylcholine and other catecholamines released into the synaptic cleft upon action potential stimulation.

Dermatological and Tissue Research

SNAP-8 is heavily researched in dermatological models investigating topical anti-aging mechanisms. Experimental models assess the compound’s ability to reduce biomechanical stress on tissue fibroblasts and epidermal constructs by mimicking botulinum toxin-like mechanisms without the associated macromolecular toxicity.

Pathway / Mechanistic Context

The primary mechanism of action for SNAP-8 in research settings revolves around the competitive inhibition of synaptic vesicle fusion.

• SNARE Assembly: Under normal conditions, the SNARE complex forms a highly stable ternary structure (combining SNAP-25, syntaxin, and synaptobrevin) that forces synaptic vesicles to fuse with the presynaptic membrane, releasing acetylcholine.
• Competitive Inhibition: SNAP-8 mimics the N-terminus of endogenous SNAP-25, competing for a position in the forming SNARE complex.
• Resulting Flux: The incorporation of SNAP-8 results in a slightly destabilized SNARE complex. This structural instability significantly impairs the thermodynamic efficiency of vesicle fusion, thereby reducing the localized release of acetylcholine and dampening subsequent signal transduction to muscle fibers.

Preclinical Research Summary

Published preclinical literature documents investigations of SNAP-8 and related SNARE-targeting peptides across multiple experimental models:

• Synaptic Vesicle Assays: In vitro data suggests that SNAP-8 application leads to a measurable decrease in the fusion rate of lipid vesicles, validating its mechanism as a fusion-machinery destabilizer.
• Neuromuscular Junction Models: Research using isolated nerve-muscle preparations indicates that treatment with SNAP-8 reduces the amplitude of miniature endplate potentials (mEPPs) by limiting presynaptic neurotransmitter pooling.
• Tissue Topography Models: Ex vivo skin models treated with SNAP-8 and its analogues observe modifications in biomechanical tension and structural folding, forming the basis for its investigation in cosmetic peptide science.

Form & Analytical Testing

This material is produced via robust chemical synthesis and supplied as a lyophilized (freeze-dried) powder.

• Lyophilization: Removes water content under vacuum to maintain compound integrity and extend shelf-life.
• Identity Verification: Each lot undergoes Mass Spectrometry (MS) to confirm molecular weight and identity.
• Purity Verification: High-Performance Liquid Chromatography (HPLC) is performed to ensure the product meets the ≥99% purity standard required for reproducible research data.

Referenced Citations

References are provided for informational purposes only and are not clinical claims.

• Gorouhi, F., & Maibach, H. I. (2009). Role of topical peptides in preventing or treating aged skin. International Journal of Cosmetic Science, 31(5), 327-345. https://doi.org/10.1111/j.1468-2494.2009.00490.x
• Schagen, S. K. (2017). Topical Peptide Treatments with Effective Anti-Aging Results. Cosmetics, 4(2), 16. https://doi.org/10.3390/cosmetics4020016
• Errante, F., Ziosi, P., Pellicioni, V., et al. (2020). Cosmeceutical Peptides in the Framework of Sustainable Wellness Medicines. Frontiers in Chemistry, 8, 572923. https://doi.org/10.3389/fchem.2020.572923
• Blanes-Mira, C., Clemente, J., Jodas, G., et al. (2002). A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science, 24(5), 303-310. https://doi.org/10.1046/j.1467-2494.2002.00153.x (Note: Foundational structural reference for the SNAP-25 analogue pathway).

• Stable at room temperature for up to 90 days. For long-term storage, keep at -20°C (-4°F) or colder.
• Once mixed with a solvent (e.g., bacteriostatic water), the solution must be stored at 4 °C (39°F) and utilized within 30 days. Avoid repeated freeze-thaw cycles, as this degrades the peptide structure.

RESEARCH USE ONLY

This product is intended strictly for laboratory research use only. It is not for human or veterinary use. It is not intended for diagnosis, treatment, cure, or prevention of any disease. All purchases are subject to our Terms of Service and Purity Guarantee.

No COAs available for this product.